GO
Loading...

ImmunoGen CEO on Competitive Cancer Drug Landscape

Monday, 4 Jun 2012 | 6:15 PM ET

Daniel Junius, ImmunoGen chairman/CEO, discusses the latest developments in therapeutics for the treatment of cancer.